Vireo Growth Inc. ( VREOF) - Stock Earnings
VREOF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -9.7 million USD | 48.1 million USD |
| 2025Q3 | -4.2 million USD | 91.7 million USD |
| 2025Q4 | -11.3 million USD | 104.5 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
VREOF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -25.5 million USD | 88.1 million USD |
| 2024 | -28.0 million USD | 99.4 million USD |
| 2025 | -42.2 million USD | 268.8 million USD |
| 2026 Est. | — | — |
VREOF
Price: $12.58
52 week price:
Earnings Per Share: -0.16 USD
P/E Ratio: -2.60
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 481.1 million